Trans-cinnamaldehyde targets VASH1 to reverse microtubule detyrosination and cardiac hypertrophy.
- DOI
- 10.1016/j.ejphar.2026.179485
- Published
- 2026-10-23
- Container
- Eur J Pharmacol
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejphar.2026.179485,
title = {Trans-cinnamaldehyde targets VASH1 to reverse microtubule detyrosination and cardiac hypertrophy.},
author = {Shan X and Yang S and Yao R and Huang J and Li R and Zhao P and Guo W and Chen H and Lu R and Zhang C.},
year = {2026},
journal = {Eur J Pharmacol},
doi = {10.1016/j.ejphar.2026.179485},
url = {https://doi.org/10.1016/j.ejphar.2026.179485}
}RIS
TY - JOUR TI - Trans-cinnamaldehyde targets VASH1 to reverse microtubule detyrosination and cardiac hypertrophy. AU - Shan X AU - Yang S AU - Yao R AU - Huang J AU - Li R AU - Zhao P AU - Guo W AU - Chen H AU - Lu R AU - Zhang C. PY - 2026 JO - Eur J Pharmacol DO - 10.1016/j.ejphar.2026.179485 UR - https://doi.org/10.1016/j.ejphar.2026.179485 ER -
APA
X, S., S, Y., R, Y., J, H., R, L., P, Z., W, G., H, C., R, L., & C., Z. (2026). Trans-cinnamaldehyde targets VASH1 to reverse microtubule detyrosination and cardiac hypertrophy.. Eur J Pharmacol. https://doi.org/10.1016/j.ejphar.2026.179485
Source records
- europe-pmc · retrieved 2026-11-10T11:38:55.085Z